The Guardian: What’s next for women’s health tech?

Apps tracking hormones and a gadget combatting menopausal hot flushes are some of the latest innovations in the femtech market, which is predicted to be worth $60bn by 2027.

When lifelong worrier Louise Stevenson asked her husband whether her anxiety was damaging, his answer stopped her in her tracks. “He said it had a negative impact on absolutely everything.” It was the prompt she needed to seek help.